We use cookies to improve your experience on this site. By viewing our pages, you give us consent to use cookies. Find out more.

Don’t invest unless you’re prepared to lose all the money you invest. NextFin promotes high - risk investments and you are unlikely to be protected if something goes wrong.
Take 2 minutes to learn more.

Equity Crowdfunding Pitches

Showing results
Optimise BP, the debut product by Optimise Health, introduces an innovative digital solution that offers secure and efficient semi-automated blood pressure management within primary care, focusing on hypertension. This advancement is projected to lead to substantial appointment savings in the range of millions.
days to go: TBC investment: £127,001
Carocell Bio is innovating by developing patented anti-inflammatory peptides delivered via nanoparticles to address severe inflammatory conditions such as atopic dermatitis. Their primary peptide, JEL0305, not only halts inflammation but also prevents its initiation, as evidenced by its effectiveness in reducing inflammation in human AD biopsies and burn tissue. With AD impacting a substantial population and costing $21 billion yearly for unsafe treatments, Carocell Bio's safer peptide remedy has the potential to avert AD recurrence. Additionally, their pioneering approach to skin-related inflammation involves topical peptide products that target mitogen-activated protein kinase (MAPK), a crucial element in inflammation. This breakthrough offers promise for managing and forestalling AD and mitigating skin aging.
days to go: Extended investment: Withheld
PULMOBIOMED is addressing the failings of current lung tests, which are expensive, infrequent, and invasive. Their so-called "clinically proven" solution claims to offer non-invasive liquid samples from deep within the lung, promising affordable tests for lung diseases. They assert that their product can empower clinicians to diagnose and treat conditions like lung cancer and infections, even though there's limited evidence to support these claims. With a few customers in the USA and Australia, and vague partnerships in the EU, PULMOBIOMED hopes to disrupt the asthma diagnostics market by introducing what they call a comprehensive diagnostic test for asthma, despite the skepticism around their capabilities.
days to go: Extended investment: £295,000
Love2move has developed a platform to bridge the gap between sellers/ homeowners and the market. It functions as an internet estate agent working in collaboration with well- established estate agents with a physical office. This way Love2move provides its users the best of both traditional as well as online estate agents. With the help of online sales platform, the agents can list homes without much setup costs involved.
days to go: Expired investment: £51,850
Canny make and sell all natural flavoured milkshakes which are already being listed in stores across the UK and on Virgin trains. The 100% natural drinks provide 11 grams of protein per bottle and have less than 5% sugar, and will be launching a no refined sugar option this summer.
days to go: Expired investment: £172,780
The Halal Dining Club is a mobile app that has been designed to allow you to search your local area for catering establishments that offer Halal dishes. The Halal Dining Club allows you to search, book, review and get rewards all in one easy-to-use app.
days to go: Expired investment: £200,550
EeBriaTrade is a craft beer, cider and other drinks distributor, representing over 500 top breweries from across the UK and abroad. EeBria adopts a unique B2B marketplace model where, unlike other conventional distributors, the operation is entirely online. Since its launch in 2015, EeBria has witnessed strong growth in the UK with over 100% YoY growth in 2018, c.200% in 2017 and c.600% in 2016, and total sales of over £6.2m. It is raising funds to make its business global and planning to launch in at least eight new countries in 2019. EeBriaTrade is expected to see even faster growth in 2019 due to progress with Pub Chains, and because of new deals signed at the end of 2018 with Costcutter (1,700 stores) and NISA (2,000 stores).
days to go: Expired investment: £235,780
Tart is a premium coffee shop and bakery serving various high-quality foods such as gourmet hot drinks, savoury tarts, baked goods and fresh salads. They cater for both customers who are on-the-go, as well as those who would like to sit and eat in comfortable surroundings. They are currently seeking funding to expand their business into multiple branches as rapid as 2019.
days to go: Expired investment: £291,859
I Am The Agent are a data-driven property hub charging property owners fixed-price online sales and rental packages. Since launching in 2011, the company has served over 150,000 clients and has achieved nearly £700k revenue. 
days to go: Expired investment: £206,310
With support from the founders of Bulldog Skincare, Zoopla and Love Film, VITL's aim is to improve the nation's health by offering vitamin packs that are fully personalised to the customer. VITL uses artificial intelligence to decipher which nutrients a person needs to ensure a healthy lifestyle. Effectively cutting out the cost of a private nutritionist.

Pitch Rated

44%

Insufficient Data

rating powered by

CROWD RATING™

days to go: Expired investment: £908,950
  • Internet Business Awards Category Award Winner 2015
  • Hertfordshire Business Awards Finalist 2014

As seen in:

  • The Guardian
  • Financial Times
  • Yahoo! Finance
  • The Times
  • The Daily Telegraph